PO.PS01.05 · 人群科学

Mining social determinants of health documentation patterns for genitourinary cancer patients using natural language processing

编号 2358 展板 24 时间 4/20 09:00–12:00 区域 Section 36 主讲 Nikita Thakur, MS
分会场 Epidemiology: Cancer Incidence, Mortality, Patterns, and Methodology
该海报暂无可访问的完整资料 AACR 官方页面 ↗

作者与单位

Nikita Thakur1, Natalie Reizine1, Karine Tawagi1, Charbel Hobeika1, Ashwani Tanwar2, Guanyu Tao2, Marzana Chowdhury2, Evan Garrad3, Ahsan Wahab1, Jingqing Zhang2, Vibhor Gupta4, VK Gadi1, Sandeep Kataria1

1University of Illinois Cancer Center, Chicago, IL,2Pangaea Data, London, United Kingdom,3University of Illinois Chicago, Chicago, IL,4Pangaea Data, South San Francisco, CA

摘要 Abstract

Mounting evidence demonstrates that social determinants of health (SDOH) significantly impact cancer care, contributing to persistent disparities in prevention, diagnosis, treatment access and survival rates that disproportionately affect vulnerable populations. However, SDOH are frequently underreported in clinical notes, obscuring barriers for patients to receive appropriate care. The systematic extraction from clinical notes remains challenging. We developed an advanced Natural Language Processing (NLP) based Artificial Intelligence (AI) platform to automatically extract SDOH from genitourinary cancer clinical notes. We analyzed 757,757 clinical notes from 5,585 patients (prostate:n=3,772; bladder:n=619; renal:n=1,194, based on ICD) using the AI platform. The platform used NLP to extract 19 types of SDOH features (e.g. race, ethnicity, health literacy, substance abuse, financial strain, social isolation, etc) across four note types: Progress Notes, Consults, Care Plans, Patient Instructions. The AI platform extracted 767,000 SDOH mentions from 4,464 patients (80% of patients). 140 clinical notes across 21 patients were randomly selected to evaluate AI accuracy. Of 140 notes, AI found SDOH features in 131 notes and clinicians from University of Illinois Cancer Center manually determined that 124 notes contained fully accurate SDOH extractions, while 7 notes had partially inaccurate SDOH extractions, yielding 95% accuracy (124/131). The study showed high prevalence of mentions of health literacy (96.71%), substance use (93.15%), and mood/affect issues (81.41%). 65% patients had minimal SDOH documentation (1.4 features per patient) and 35% patients had multiple SDOH documentation (6.9 features per patient). Among 2,900 patients who were diagnosed with genitourinary cancer in 2018-2023 (317,143 SDOH mentions after removing boilerplate SDOH mentions), by analyzing COVID-19 impact (pre vs post March 2020), we found that documentation of demographic SDOH decreased, e.g. home address (-37%), race (-34%), ethnicity (-36%), but the social SDOH increased, e.g. social isolation (+65%), financial strain (+76%), stress (+63%). This study shows the feasibility and effectiveness of using NLP to systematically extract SDOH from genitourinary cancer clinical notes. The high prevalence of documented SDOH underscores their potential impact on cancer care delivery and emphasizes the importance of routine SDOH documentation for every patient. COVID-19 caused a significant shift in SDOH documentation patterns with more pandemic-exacerbated social barriers. Future work should focus on validating the clinical impact of SDOH-informed decision making. Additional directions include leveraging large language models (LLMs) to infer the presence or impact of SDOH features and analyzing extracted SDOH information for clinical and societal insights.
利益披露 Disclosure
N. Thakur, None. N. Reizine, Astrazeneca Independent Contractor. Merck Independent Contractor. Tempus Independent Contractor. Janssen Independent Contractor. Dava Oncology Travel. K. Tawagi, AstraZeneca Other, Speaker's Bureau. Seagen Other, Advisory Board. Pfizer Other, Advisory Board. OncLive Other, Invited Speaker. C. Hobeika, None. A. Tanwar, Pangaea Data Employment. G. Tao, Pangaea Data Employment. M. Chowdhury, Pangaea Data Employment. E. Garrad, None.. A. Wahab, None. J. Zhang, Pangaea Data Employment, Stock Option. V. Gupta, Pangaea Data Employment, Stock, Other Business Ownership. V. Gadi, TempusAI Stock. Novartis Other, Advisory Board. Novilla Stock. Phoenix Molecular Designs Stock. Gilead Other, Advisory Board. Illumina ). Hologic Other, Advisory Board. Puma Other, Advisory Board. Stemline Other, Advisory Board. AstraZeneca Other, Advisory Board. Lilly Other, Advisory Board. 3rdEyeBio Stock. S. Kataria, None.

在会议检索中打开